AR009698A1 - Cuerpo configurados para ser utilizados como implantes en mediciona humana, y procedimiento de preparacion de tales cuerpo configurados - Google Patents

Cuerpo configurados para ser utilizados como implantes en mediciona humana, y procedimiento de preparacion de tales cuerpo configurados

Info

Publication number
AR009698A1
AR009698A1 ARP980105229A ARP980105229A AR009698A1 AR 009698 A1 AR009698 A1 AR 009698A1 AR P980105229 A ARP980105229 A AR P980105229A AR P980105229 A ARP980105229 A AR P980105229A AR 009698 A1 AR009698 A1 AR 009698A1
Authority
AR
Argentina
Prior art keywords
implants
preparation procedure
human
catalyst
temperatures
Prior art date
Application number
ARP980105229A
Other languages
English (en)
Original Assignee
Artimplant Dev Artdev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artimplant Dev Artdev Ab filed Critical Artimplant Dev Artdev Ab
Publication of AR009698A1 publication Critical patent/AR009698A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08—Processes
    • C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/4236—Polycondensates having carboxylic or carbonic ester groups in the main chain containing only aliphatic groups
    • C08G18/4238—Polycondensates having carboxylic or carbonic ester groups in the main chain containing only aliphatic groups derived from dicarboxylic acids and dialcohols
    • C08G18/4241—Polycondensates having carboxylic or carbonic ester groups in the main chain containing only aliphatic groups derived from dicarboxylic acids and dialcohols from dicarboxylic acids and dialcohols in combination with polycarboxylic acids and/or polyhydroxy compounds which are at least trifunctional
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
    • C08G18/4269—Lactones
    • C08G18/4277—Caprolactone and/or substituted caprolactone

Abstract

Cuerpos configurados para ser utilizados como implantes en medicina humana y veterinaria, en forma de pernos, tornillos, disco y fijaciones deligamentos y similares, consisten en poliuretanos que tienen ligaduras éster que pueden ser hidrolizadasen el cuerpo humano dando lugar a fragmentos dehidrolisis suficientemente pequenos para ser reabsorbidos en el cuerpo humano. Los cuerpos configurados están caracterizados en que el polímero es un polímeroreticulado sustancialmente exento de gruposurea. También se refiere a un procedimiento para la produccion de cuerpos configurados, que consiste en queuna mezcla de materia prima adecuadas es introducida en moldes y curada a temperaturas de 70 a 150*C en ausencia de catalizador ya temperaturas de 30 a100°C en presencia de catalizador.
ARP980105229A 1997-11-03 1998-10-20 Cuerpo configurados para ser utilizados como implantes en mediciona humana, y procedimiento de preparacion de tales cuerpo configurados AR009698A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704003A SE510868C2 (sv) 1997-11-03 1997-11-03 Formkroppar för användning som implantat i humanmedicin samt förfarande för framställning av sådana formkroppar

Publications (1)

Publication Number Publication Date
AR009698A1 true AR009698A1 (es) 2000-04-26

Family

ID=20408832

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105229A AR009698A1 (es) 1997-11-03 1998-10-20 Cuerpo configurados para ser utilizados como implantes en mediciona humana, y procedimiento de preparacion de tales cuerpo configurados

Country Status (28)

Country Link
US (1) US6436136B1 (es)
EP (1) EP1027086B1 (es)
JP (1) JP2001521788A (es)
KR (1) KR20010031738A (es)
AR (1) AR009698A1 (es)
AT (1) ATE216271T1 (es)
AU (1) AU740604B2 (es)
BR (1) BR9812774A (es)
CA (1) CA2308190A1 (es)
DE (1) DE69804989T2 (es)
DK (1) DK1027086T3 (es)
EE (1) EE200000760A (es)
ES (1) ES2175795T3 (es)
HK (1) HK1030168A1 (es)
HR (1) HRP20000242A2 (es)
HU (1) HUP0004017A3 (es)
IL (1) IL135935A0 (es)
NO (1) NO20002292L (es)
NZ (1) NZ504190A (es)
PL (1) PL343839A1 (es)
PT (1) PT1027086E (es)
SE (1) SE510868C2 (es)
SK (1) SK6532000A3 (es)
TR (1) TR200001223T2 (es)
TW (1) TW501933B (es)
WO (1) WO1999022780A1 (es)
YU (1) YU24100A (es)
ZA (1) ZA989694B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140049A0 (en) * 1998-06-05 2002-02-10 Polyganics Bv Biomedical polyurethane, its preparation and use
GB0116341D0 (en) * 2001-07-04 2001-08-29 Smith & Nephew Biodegradable polymer systems
GB0202233D0 (en) * 2002-01-31 2002-03-20 Smith & Nephew Bioresorbable polymers
US8025685B2 (en) * 2003-08-06 2011-09-27 Kenneth Stewart Bone instrumentation cover or shield
DE10340392A1 (de) * 2003-09-02 2005-04-07 Mnemoscience Gmbh Amorphe Polyesterurethan-Netzwerke mit Form-Gedächtnis-Eigenschaften
US7141354B2 (en) * 2003-09-30 2006-11-28 Dai Nippon Printing Co., Ltd. Photo radical generator, photo sensitive resin composition and article
GB0329654D0 (en) 2003-12-23 2004-01-28 Smith & Nephew Tunable segmented polyacetal
DE102004057699A1 (de) * 2004-11-30 2006-06-01 Henkel Kgaa Zwei-Komponenten-Polyurethanklebstoffe, Additive für Zwei-Komponenten-Polyurethanklebstoffe und Verwendung der Additive
WO2007103276A2 (en) 2006-03-03 2007-09-13 Smith & Nephew, Inc. Systems and methods for delivering a medicament
CN101594831B (zh) 2006-11-30 2011-09-14 史密夫和内修有限公司 纤维增强的复合材料
JP5416090B2 (ja) 2007-04-18 2014-02-12 スミス アンド ネフュー ピーエルシー 形状記憶ポリマーの膨張成形
EP2142227B1 (en) 2007-04-19 2012-02-29 Smith & Nephew, Inc. Multi-modal shape memory polymers
DE602008006181D1 (de) 2007-04-19 2011-05-26 Smith & Nephew Inc Graft-fixierung
EP2385960B1 (en) 2009-01-12 2020-03-11 University Of Massachusetts Lowell Polyisobutylene-based polyurethanes
JP6581303B2 (ja) * 2015-12-17 2019-09-25 カーディアック ペースメイカーズ， インコーポレイテッド ポリイソブチレン−ポリウレタンを含むポリマー材料およびそれを含む医療デバイス並びに同ポリマー材料を製造する方法
WO2018165273A1 (en) 2017-03-07 2018-09-13 Cardiac Pacemakers, Inc. Hydroboration/oxidation of allyl-terminated polyisobutylene
US11472911B2 (en) 2018-01-17 2022-10-18 Cardiac Pacemakers, Inc. End-capped polyisobutylene polyurethane

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE505703C2 (sv) 1995-12-15 1997-09-29 Polyrand Ab Linjär blockpolymer innefattande urea- och uretangrupper, förfarande för framställning av linjära blockpolymerer samt användning av blockpolymererna som implantat
DE3689650T2 (de) * 1985-12-17 1994-05-26 United States Surgical Corp Bioresorbierbare Polymere von hohem Molekulargewicht und Implantate davon.
NL8703115A (nl) * 1987-12-23 1989-07-17 Groningen Science Park Biodegradeerbare polyurethanen, daarop gebaseerde voortbrengselen, en polyesterpolyol prepolymeren.
US5502158A (en) * 1988-08-08 1996-03-26 Ecopol, Llc Degradable polymer composition
WO1994009048A1 (en) * 1992-10-13 1994-04-28 Rijksuniversiteit Te Groningen Polyurethane network for biomedical use
US6221997B1 (en) * 1997-04-28 2001-04-24 Kimberly Ann Woodhouse Biodegradable polyurethanes

Also Published As

Publication number Publication date
IL135935A0 (en) 2001-05-20
SE510868C2 (sv) 1999-07-05
PL343839A1 (en) 2001-09-10
ZA989694B (en) 1999-04-29
PT1027086E (pt) 2002-09-30
JP2001521788A (ja) 2001-11-13
BR9812774A (pt) 2000-10-10
HUP0004017A2 (en) 2001-03-28
ATE216271T1 (de) 2002-05-15
TW501933B (en) 2002-09-11
YU24100A (sh) 2001-09-28
DE69804989T2 (de) 2002-11-21
ES2175795T3 (es) 2002-11-16
SE9704003D0 (sv) 1997-11-03
NO20002292D0 (no) 2000-04-28
EP1027086A1 (en) 2000-08-16
NZ504190A (en) 2002-09-27
TR200001223T2 (tr) 2002-01-21
SK6532000A3 (en) 2000-09-12
WO1999022780A1 (en) 1999-05-14
CA2308190A1 (en) 1999-05-14
NO20002292L (no) 2000-06-23
SE9704003L (sv) 1999-05-04
AU740604B2 (en) 2001-11-08
HK1030168A1 (en) 2001-04-27
KR20010031738A (ko) 2001-04-16
DK1027086T3 (da) 2002-08-12
US6436136B1 (en) 2002-08-20
HUP0004017A3 (en) 2003-10-28
EP1027086B1 (en) 2002-04-17
EE200000760A (et) 2002-04-15
HRP20000242A2 (en) 2001-02-28
DE69804989D1 (de) 2002-05-23
AU9564398A (en) 1999-05-24

Similar Documents

Publication Publication Date Title
AR009698A1 (es) Cuerpo configurados para ser utilizados como implantes en mediciona humana, y procedimiento de preparacion de tales cuerpo configurados
Zeng et al. Approaches to cutaneous wound healing: basics and future directions
Tseng et al. An injectable, self‐healing hydrogel to repair the central nervous system
ES2720292T3 (es) Método para fabricar aplicaciones de alimentos humanos o productos intermedios para aplicaciones no alimentarias y aplicaciones de alimentos humanos o productos intermedios para aplicaciones no alimentarias
ES2080837T3 (es) Tratamiento de estados y enfermedades.
AR003108A1 (es) Compuestos con propiedades de liberacion de la hormona del crecimiento, composicion farmaceutica que los contienen, el uso de los mismos para la preparación de un medicamento.
ES2571856T3 (es) Uso de composiciones nutricionales para prevenir la adiposidad visceral
Evans Macrophage requirement for growth of a murine fibrosarcoma.
Campitiello et al. To evaluate the efficacy of an acellular flowable matrix in comparison with a wet dressing for the treatment of patients with diabetic foot ulcers: a randomized clinical trial
AR038899A1 (es) Un medicamento para animales
ES2704681T3 (es) Tratamiento de enfermedad con nanofibras de poli-N-acetilglucosamina
AR024564A1 (es) Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico
Zaafan et al. The cardioprotective effect of astaxanthin against isoprenaline-induced myocardial injury in rats: involvement of TLR4/NF-κB signaling pathway.
JP2014231487A (ja) 卵殻膜成分を含むサーチュイン遺伝子活性化剤ならびにそれを用いた組成物
Bliss Musculoskeletal structure and physiology
Huang et al. Intradermal delivery of an angiotensin II receptor blocker using a personalized microneedle patch for treatment of hypertrophic scars
WO2020022131A1 (ja) 皮膚の抗老化用剤及び抗老化関連遺伝子発現調節用剤
AR016254A1 (es) Una composicion de celulas de tumor modificadas con un hapteno o extracto de celulas tumorales y uso de la misma en la elaboracion de un medicamento.
Chen et al. Role of macrophage polarization in osteoarthritis
CN113679875A (zh) 一种可吸收医用手术线及其制备方法
Kim et al. Effect of A. polygama APEE (Actinidia polygama ethanol extract) or APWE (Actinidia polygama water extract) on wrinkle formation in UVB‐irradiated hairless mice
Washio et al. Propolis ethanol extract stimulates cytokine and chemokine production through NF-κB activation in C2C12 myoblasts
Fritz et al. Comparison of native porcine skin and a dermal substitute using tensiometry and digital image speckle correlation
AR000519A1 (es) Productos alimenticios hechos de enzima proteasa método para su preparación y método para inactivar la enzima proteasa en el pescado
KR101696646B1 (ko) 조직 고정용 필라멘트

Legal Events

Date Code Title Description
FA Abandonment or withdrawal